Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles
Excessive inflammation and failed resolution of the inflammatory response are underlying components of numerous conditions such as arthritis, cardiovascular disease, and cancer. Hence, therapeutics that dampen inflammation and enhance resolution are of considerable interest. In this study, we demons...
Main Authors: | Farokhzad, Omid C., Gadde, Suresh, Kamaly, Nazila, Fredman, Gabrielle, Subramanian, Manikandan, Pesic, Aleksandar, Cheung, Louis, Fayad, Zahi A., Tabas, Ira, Langer, Robert S |
---|---|
Other Authors: | Massachusetts Institute of Technology. Institute for Medical Engineering & Science |
Format: | Article |
Language: | en_US |
Published: |
National Academy of Sciences (U.S.)
2013
|
Online Access: | http://hdl.handle.net/1721.1/83355 https://orcid.org/0000-0002-2640-3006 https://orcid.org/0000-0002-6910-1905 https://orcid.org/0000-0003-4255-0492 |
Similar Items
-
Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles
by: Langer, Robert, et al.
Published: (2013) -
Nanomedicines for endothelial disorders
by: Toth, Michael J., et al.
Published: (2018) -
Surface Charge-Switching Polymeric Nanoparticles for Bacterial Cell Wall-Targeted Delivery of Antibiotics
by: Radovic-Moreno, Aleksandar F., et al.
Published: (2014) -
Synergistic cytotoxicity of irinotecan and cisplatin in dual-drug targeted polymeric nanoparticles
by: Valencia, Pedro M, et al.
Published: (2015) -
Mass Production and Size Control of Lipid–Polymer Hybrid Nanoparticles through Controlled Microvortices
by: Kim, YongTae, et al.
Published: (2014)